Status: Recruiting
The Vizio Clinical Study
Evaluate the Safety and Efficacy of the Vizio Aqueous Microshunt for the Treatment of Refractory Glaucoma
Participants needed: 50
Trial details
Age: 22-85Biological sex: AllType: InterventionalSponsor: OcumedexUpdated: Jul 10, 2026Locations: 1
Eligibility criteria
Age 22-85 years [+12]
Active neovascular conditions such as active iris or corneal neovascularization,... [+24]